OAinject: Fighting osteoarthritis
In the Netherlands, more than 1.5 million people suffer from osteoarthritis – a chronic degenerative rheumatic condition of the joints that causes pain, stiffness and restriction in daily moving. As osteoarthritis is a condition that mainly occurs among older people, the number of patients is set to greatly increase due to the ageing of Dutch society. At present, there is no adequate treatment for osteoarthritis.
Maastricht University is part of the OAinject consortium, funded by the Perspectief program of the Dutch Research Council (NWO), that will develop new diagnostic tools to determine which form of osteoarthritis a patient has. This way more accurate individualised treatments can be offered in the future. The researchers will also work on innovative ways of gradually administering drugs locally over a extended period of time via an injectable drug depot in the diseased joint. With this approach, the consortium aims to develop novel methods that are expected to support a durable active lifestyle for osteoarthritis patients.
Our CAPHRI/ MUMC+ researchers Tim Welting and Pieter Emans from the Department of Orthopedic Surgery are co-initiator and member of the OAinject project. The project is led by Marcel Karperien of the University of Twente.
Consortium
Programme leader: Prof. Marcel Karperien (University of Twente)
Participating knowledge institutions: Delft University of Technology, Erasmus MC, Maastricht University, Maastricht University Medical Center, Radboud university medical center, University Medical Center Utrecht, University of Twente
Companies: Chondropeptix, DSM Biomedical, IBIS Technologies, InnoCore Pharmaceuticals, 20Med Therapeutics, Nordic Bioscience, Orthros Medical, Procore, QVQ, Ssens
Other societal partners: Deventer Hospital, ReumaNederland, Dutch Society for the Replacement of Animal Testing
Prof. dr. Tim Welting, PhD
Professor of Molecular Cartilage Biology
Ad interim Chair of the Department of Orthopedic Surgery
Head of the Laboratory for Experimental Orthopedics
t.welting@maastrichtuniversity.nl
Video
Also read
-
Interprofessional collaboration and learning in primary care
Loes van Bokhoven (CAPHRI) aims to improve care in GP practices and contribute to the personnel challenges in the region.
-
New insight into the role of brain changes in psychiatric disorders
It has long been known that in some psychiatric disorders certain parts of the brain show slight abnormalities. However, it was unclear whether these brain changes are caused by the illness itself, by medication, or by smoking. In a recent study, scientists at Maastricht University and Amsterdam UMC...
-
Diana Kramp – A contribution to care through knowledge and experience
Is improving healthcare only a task for our healthcare and academic staff? At first glance, you would say so. But sometimes there are colleagues within our health faculty who experience care themselves, and feel an urge to contribute to it from a patient perspective. You find this quality in Diana...
